Brown Brothers Harriman & CO Edwards Lifesciences Corp Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 1,006 shares of EW stock, worth $73,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,006

Previous 960 4.79%

Holding current value

$73,025

Previous $88,000 25.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$59.7 - $93.78 $2,746 - $4,313	46 Added 4.79%	1,006 $66,000
Q2 2024 Aug 09, 2024	SELL	$84.3 - $94.31 $21,412 - $23,954	-254 Reduced 20.92%	960 $88,000
Q1 2024 May 10, 2024	SELL	$72.54 - $95.56 $11,824 - $15,576	-163 Reduced 11.84%	1,214 $116,000
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $12,959 - $16,329	-210 Reduced 13.23%	1,377 $104,000
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $16,765 - $22,597	-242 Reduced 13.23%	1,587 $109,000
Q2 2023 Aug 07, 2023	BUY	$81.41 - $94.33 $40,786 - $47,259	501 Added 37.73%	1,829 $172,000
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $23,391 - $26,620	315 Added 31.1%	1,328 $109,000
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $819 - $1,049	-12 Reduced 1.17%	1,013 $75,000
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $28,005 - $36,478	340 Added 49.64%	1,025 $85,000
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $11,937 - $17,701	138 Added 25.23%	685 $65,000
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $40,784 - $51,336	-400 Reduced 42.24%	547 $64,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $87,967 - $108,072	-827 Reduced 46.62%	947 $123,000
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $86,650 - $103,355	842 Added 90.34%	1,774 $201,000
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $7,126 - $8,904	-85 Reduced 8.36%	932 $97,000
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $1,652 - $1,904	21 Added 2.11%	1,017 $85,000
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $46,240 - $58,843	645 Added 183.76%	996 $91,000
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $403 - $524	6 Added 1.74%	351 $28,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $13,579 - $18,160	236 Added 216.51%	345 $24,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $7,547 - $11,664	-144 Reduced 56.92%	109 $21,000
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $3,446 - $4,224	56 Added 28.43%	253 $56,000
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $1,059 - $1,223	19 Added 10.67%	197 $36,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $4,645 - $6,212	97 Added 119.75%	178 $34,000
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $2,320 - $2,847	50 Added 161.29%	81 $12,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $1,279 - $1,624	-28 Reduced 47.46%	31 $5,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $4,711 - $5,694	-111 Reduced 65.29%	59 $9,000
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $8,628 - $11,008	-232 Reduced 57.71%	170 $24,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $5,980 - $6,972	177 Added 78.67%	402 $45,000
Q2 2017 Aug 14, 2017	BUY	N/A	225	225 $27,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Edwards Lifesciences Corp Transaction History